Slate Path Capital LP - Nov 21, 2024 Form 4 Insider Report for Cyclerion Therapeutics, Inc. (CYCN)

Role: 10%+ Owner
Signature: Slate Path Capital LP, By: Jades GP, LLC, its General Partner, By: /s/ John Metzner, its Chief Operating Officer
Stock symbol: CYCN
Transactions as of: Nov 21, 2024
Transactions value $: -$555,108
Form type: 4
Date filed: 11/25/2024, 04:05 PM
Previous filing: Jun 7, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CYCN	Common Stock, no par value	Sale	-$555K	-358K	-100%	$1.55	0	Nov 21, 2024	See footnote	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Slate Path Capital LP is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	The number of shares reported herein reflect the one-for-twenty reverse stock split effected by the Issuer on May 15, 2023.
F2	The securities to which this filing relates were held by certain funds (the "Slate Path Funds"). Slate Path Capital LP (the "Investment Manager"), a Delaware limited partnership acts as the investment manager of the Slate Path Funds. Mr. David Greenspan serves as the managing member of Jades GP, LLC, a Delaware limited liability company and the general partner of the Investment Manager. The filing of this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any.

Content

The number of shares reported herein reflect the one-for-twenty reverse stock split effected by the Issuer on May 15, 2023.

The securities to which this filing relates were held by certain funds (the "Slate Path Funds"). Slate Path Capital LP (the "Investment Manager"), a Delaware limited partnership acts as the investment manager of the Slate Path Funds. Mr. David Greenspan serves as the managing member of Jades GP, LLC, a Delaware limited liability company and the general partner of the Investment Manager. The filing of this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein, if any.

Remarks:

The Power of Attorney dated as of July 31, 2020 executed by David Greenspan authorizing Jim Feeney to sign and file this form on his behalf is attached as Exhibit 24.1 to the Reporting Persons Form 3 with respect to the Issuer filed with the Securities and Exchange Commission on August 10, 2020.